Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 133

1.

Implementation of an intensive adherence intervention in patients with second-line antiretroviral therapy failure in four west African countries with little access to genotypic resistance testing: a prospective cohort study.

Eholie SP, Moh R, Benalycherif A, Gabillard D, Ello F, Messou E, Zoungrana J, Diallo I, Diallo M, Bado G, Cisse M, Maiga AI, Anzian A, Toni TD, Congo-Ouedraogo M, Toure-Kane C, Seydi M, Minta DK, Sawadogo A, Sangaré L, Drabo J, Karcher S, Le Carrou J, de Monteynard LA, Peytavin G, Gabassi A, Girard PM, Chaix ML, Anglaret X, Landman R; Thilao ANRS 12269 Study Group.

Lancet HIV. 2019 Oct 7. pii: S2352-3018(19)30228-0. doi: 10.1016/S2352-3018(19)30228-0. [Epub ahead of print]

PMID:
31601544
2.

In Vivo CRISPR Screen Identifies TgWIP as a Toxoplasma Modulator of Dendritic Cell Migration.

Sangaré LO, Ólafsson EB, Wang Y, Yang N, Julien L, Camejo A, Pesavento P, Sidik SM, Lourido S, Barragan A, Saeij JPJ.

Cell Host Microbe. 2019 Oct 9;26(4):478-492.e8. doi: 10.1016/j.chom.2019.09.008.

PMID:
31600500
3.

Rice bran supplementation modulates growth, microbiota and metabolome in weaning infants: a clinical trial in Nicaragua and Mali.

Zambrana LE, McKeen S, Ibrahim H, Zarei I, Borresen EC, Doumbia L, Boré A, Cissoko A, Douyon S, Koné K, Perez J, Perez C, Hess A, Abdo Z, Sangaré L, Maiga A, Becker-Dreps S, Yuan L, Koita O, Vilchez S, Ryan EP.

Sci Rep. 2019 Sep 26;9(1):13919. doi: 10.1038/s41598-019-50344-4.

5.

Toxoplasma GRA15 Activates the NF-κB Pathway through Interactions with TNF Receptor-Associated Factors.

Sangaré LO, Yang N, Konstantinou EK, Lu D, Mukhopadhyay D, Young LH, Saeij JPJ.

MBio. 2019 Jul 16;10(4). pii: e00808-19. doi: 10.1128/mBio.00808-19.

6.

Why oral antiseptic mouth rinsing before sputum collection cannot reduce contamination rate of mycobacterial culture in Burkina-Faso.

Kabore A, Tranchot-Diallo J, Sanou A, Hien H, Daneau G, Gomgnimbou MK, Meda N, Sangaré L.

Afr Health Sci. 2019 Mar;19(1):1321-1328. doi: 10.4314/ahs.v19i1.3.

7.

Identification of spore-forming bacteria isolated from contaminated Lowenstein Jensen media and effectiveness of Vancomycin to reduce Mycobacterial culture contamination in Burkina-Faso.

Kaboré A, Tranchot-Diallo J, Hien H, Zouré O, Zingué D, Sanou A, Gomgnimbou MK, Daneau G, Ouédraogo GA, Méda N, Sangaré L.

Sci Rep. 2019 May 10;9(1):7194. doi: 10.1038/s41598-019-43662-0.

8.

A National Survey of Medical Oncologist's Opinions and Perceptions for Managing Rash Among mCRC Patients Treated with Panitumumab.

Lowe KA, Sangaré L, Bergstresser R, McNamara M, Kafatos G, Garawin T.

Dermatol Ther (Heidelb). 2019 Jun;9(2):337-353. doi: 10.1007/s13555-019-0296-z. Epub 2019 May 3.

9.

Multidrug-Resistant Tuberculosis in Burkina Faso from 2006 to 2017: Results of National Surveys.

Diandé S, Badoum G, Combary A, Zombra I, Saouadogo T, Sawadogo LT, Nébié B, Gnanou S, Zigani A, Ouédraogo SM, Diallo A, Kaboré S, Sangaré L.

Eur J Microbiol Immunol (Bp). 2019 Feb 6;9(1):23-28. doi: 10.1556/1886.2018.00029. eCollection 2019 Mar 18.

10.

Dermatologic Toxicities: A Chart Review of Clinical Management Among Patients With Metastatic Colorectal Cancer Treated With Panitumumab.

Lowe KA, Sangaré L, Roehl KA, Jung S, Kafatos G, Garwin T.

Clin J Oncol Nurs. 2019 Apr 1;23(2):157-164. doi: 10.1188/19.CJON.157-164.

PMID:
30880806
11.

Three Toxoplasma gondii Dense Granule Proteins Are Required for Induction of Lewis Rat Macrophage Pyroptosis.

Wang Y, Cirelli KM, Barros PDC, Sangaré LO, Butty V, Hassan MA, Pesavento P, Mete A, Saeij JPJ.

MBio. 2019 Jan 8;10(1). pii: e02388-18. doi: 10.1128/mBio.02388-18.

12.

Building Laboratory-Based Arbovirus Sentinel Surveillance Capacity During an Ongoing Dengue Outbreak, Burkina Faso, 2017.

Sanou AS, Dirlikov E, Sondo KA, Kagoné TS, Yameogo I, Sow HE, Adjami AG, Traore SM, Dicko A, Tinto B, Diendere EA, Ouedraogo-Konate SMWK, Kiemtore T, Kangoye DT, Sangare L, Dama ETH, Fuller JA, Major CG, Tosado-Acevedo R, Sharp TM, Koné RG, Bicaba BW.

Health Secur. 2018 Fall;16(S1):S103-S110. doi: 10.1089/hs.2018.0048.

PMID:
30480496
13.

Initial validation of a simulation model for estimating the impact of serogroup A Neisseria meningitidis vaccination in the African meningitis belt.

Jackson ML, Diallo AO, Médah I, Bicaba BW, Yaméogo I, Koussoubé D, Ouédraogo R, Sangaré L, Mbaeyi SA.

PLoS One. 2018 Oct 25;13(10):e0206117. doi: 10.1371/journal.pone.0206117. eCollection 2018.

14.

Management of necrotizing and non-necrotic bacterial erysipelas of the face in tropical areas: a series of four cases and a review of the literature.

Sondo KA, Diendéré EA, Ouédraogo MS, Ouédraogo GA, Diallo I, Zoungrana J, Poda A, Bognounou R, Da L, Savadogo M, Ouédraogo SM, Niamba P, Sangaré L.

Med Sante Trop. 2018 Aug 1;28(3):273-276. doi: 10.1684/mst.2018.0816. Review.

15.

[Evolution of biochemical and hematological parameters in patients living with HIV/AIDS treated with antiretroviral therapy at the Aboubacar Sangoulé Lamizana General Camp Medical Center].

Karfo R, Kabré E, Coulibaly L, Diatto G, Sakandé J, Sangaré L.

Pan Afr Med J. 2018 Mar 19;29:159. doi: 10.11604/pamj.2018.29.159.13659. eCollection 2018. French.

16.

Molecular characterization of invasive meningococcal isolates in Burkina Faso as the relative importance of serogroups X and W increases, 2008-2012.

Retchless AC, Congo-Ouédraogo M, Kambiré D, Vuong J, Chen A, Hu F, Ba AK, Ouédraogo AS, Hema-Ouangraoua S, Patel JC, Traoré RO, Sangaré L, Wang X.

BMC Infect Dis. 2018 Jul 18;18(1):337. doi: 10.1186/s12879-018-3247-x.

17.

Distribution of resistance genes encoding ESBLs in Enterobacteriaceae isolated from biological samples in health centers in Ouagadougou, Burkina Faso.

Kpoda DS, Ajayi A, Somda M, Traore O, Guessennd N, Ouattara AS, Sangare L, Traore AS, Dosso M.

BMC Res Notes. 2018 Jul 13;11(1):471. doi: 10.1186/s13104-018-3581-5.

18.

Presence of qnr genes in ESBL-producing Enterobacteriaceae strains resistant to quinolones in Ouagadougou, Burkina Faso.

Kpoda DS, Guessennd N, Sangaré L, Dosso M, Traoré AS.

Med Mal Infect. 2018 Oct;48(7):489-491. doi: 10.1016/j.medmal.2018.04.391. Epub 2018 May 9. No abstract available.

PMID:
29753530
19.

Impact and effectiveness of pentavalent rotavirus vaccine in children <5 years of age in Burkina Faso.

Bonkoungou IJO, Aliabadi N, Leshem E, Kam M, Nezien D, Drabo MK, Nikiema M, Ouedraogo B, Medah I, Konaté S, Ouédraogo-Traoré R, Sangaré L, Kam L, Yé D, Ouattara M, Biey JN, Mwenda JM, Tate JE, Parashar UD.

Vaccine. 2018 Nov 12;36(47):7170-7178. doi: 10.1016/j.vaccine.2017.12.056. Epub 2017 Dec 28.

PMID:
29290478
20.

Dengue Fever in Burkina Faso, 2016.

Tarnagda Z, Cissé A, Bicaba BW, Diagbouga S, Sagna T, Ilboudo AK, Tialla D, Lingani M, Sondo KA, Yougbaré I, Yaméogo I, Sow HE, Sakandé J, Sangaré L, Greco R, Muscatello DJ.

Emerg Infect Dis. 2018 Jan;24(1):170-172. doi: 10.3201/eid2401.170973.

21.

Early impact of 13-valent pneumococcal conjugate vaccine on pneumococcal meningitis-Burkina Faso, 2014-2015.

Kambiré D, Soeters HM, Ouédraogo-Traoré R, Medah I, Sangaré L, Yaméogo I, Sawadogo G, Ouédraogo AS, Ouangraoua S, McGee L, Srinivasan V, Aké F, Congo-Ouédraogo M, Ky Ba A, Whitney CG, Novak RT, Van Beneden C; MenAfriNet Consortium.

J Infect. 2018 Mar;76(3):270-279. doi: 10.1016/j.jinf.2017.12.002. Epub 2017 Dec 15.

22.

Bacterial meningitis epidemiology and return of Neisseria meningitidis serogroup A cases in Burkina Faso in the five years following MenAfriVac mass vaccination campaign.

Diallo AO, Soeters HM, Yameogo I, Sawadogo G, Aké F, Lingani C, Wang X, Bita A, Fall A, Sangaré L, Ouédraogo-Traoré R, Medah I, Bicaba B, Novak RT; MenAfriNet Consortium.

PLoS One. 2017 Nov 2;12(11):e0187466. doi: 10.1371/journal.pone.0187466. eCollection 2017.

23.

AQ-13, an investigational antimalarial, versus artemether plus lumefantrine for the treatment of uncomplicated Plasmodium falciparum malaria: a randomised, phase 2, non-inferiority clinical trial.

Koita OA, Sangaré L, Miller HD, Sissako A, Coulibaly M, Thompson TA, Fongoro S, Diarra Y, Ba M, Maiga A, Diallo B, Mushatt DM, Mather FJ, Shaffer JG, Anwar AH, Krogstad DJ.

Lancet Infect Dis. 2017 Dec;17(12):1266-1275. doi: 10.1016/S1473-3099(17)30365-1. Epub 2017 Sep 12.

24.

Novel Aflatoxin-Degrading Enzyme from Bacillus shackletonii L7.

Xu L, Eisa Ahmed MF, Sangare L, Zhao Y, Selvaraj JN, Xing F, Wang Y, Yang H, Liu Y.

Toxins (Basel). 2017 Jan 14;9(1). pii: E36. doi: 10.3390/toxins9010036.

25.

The Establishment and Diversification of Epidemic-Associated Serogroup W Meningococcus in the African Meningitis Belt, 1994 to 2012.

Retchless AC, Hu F, Ouédraogo AS, Diarra S, Knipe K, Sheth M, Rowe LA, Sangaré L, Ky Ba A, Ouangraoua S, Batra D, Novak RT, Ouédraogo Traoré R, Wang X.

mSphere. 2016 Nov 16;1(6). pii: e00201-16. eCollection 2016 Nov-Dec.

26.

Nationwide Trends in Bacterial Meningitis before the Introduction of 13-Valent Pneumococcal Conjugate Vaccine-Burkina Faso, 2011-2013.

Kambiré D, Soeters HM, Ouédraogo-Traoré R, Medah I, Sangare L, Yaméogo I, Sawadogo G, Ouédraogo AS, Hema-Ouangraoua S, McGee L, Srinivasan V, Aké F, Congo-Ouédraogo M, Sanou S, Ba AK, Novak RT, Van Beneden C; MenAfriNet Consortium.

PLoS One. 2016 Nov 10;11(11):e0166384. doi: 10.1371/journal.pone.0166384. eCollection 2016.

27.

West Africa International Centers of Excellence for Malaria Research: Drug Resistance Patterns to Artemether-Lumefantrine in Senegal, Mali, and The Gambia.

Dieye B, Affara M, Sangare L, Joof F, Ndiaye YD, Gomis JF, Ndiaye M, Mbaye A, Diakite M, Sy N, Mbengue B, Deme AB, Daniels R, Ahouidi AD, Dieye T, Abdullahi A, Doumbia S, Ndiaye JL, Diarra A, Ismaela A, Coulibaly M, Welty C, Ngwa AA, Shaffer J, D'Alessandro U, Volkman SK, Wirth DF, Krogstad DJ, Koita O, Nwakanma D, Ndiaye D.

Am J Trop Med Hyg. 2016 Nov 2;95(5):1054-1060. Epub 2016 Aug 22.

28.

Inactivation of Prions and Amyloid Seeds with Hypochlorous Acid.

Hughson AG, Race B, Kraus A, Sangaré LR, Robins L, Groveman BR, Saijo E, Phillips K, Contreras L, Dhaliwal V, Manca M, Zanusso G, Terry D, Williams JF, Caughey B.

PLoS Pathog. 2016 Sep 29;12(9):e1005914. doi: 10.1371/journal.ppat.1005914. eCollection 2016 Sep.

29.

[Obstetric endometritis at the UTH-Yalgado Ouedraogo of Ouagadougou (Burkina Faso): about the management of 102 cases].

Ouédraogo CM, Ouattara A, Sana A, Ouédraogo A, Kain DP, Komboigo E, Sangaré L, Lankoandé J.

Bull Soc Pathol Exot. 2016 Dec;109(5):334-339. doi: 10.1007/s13149-016-0514-1. Epub 2016 Jul 23. French.

PMID:
27448579
30.

High prevalence of extended-spectrum ß-lactamase producing enterobacteriaceae among clinical isolates in Burkina Faso.

Ouedraogo AS, Sanou M, Kissou A, Sanou S, Solaré H, Kaboré F, Poda A, Aberkane S, Bouzinbi N, Sano I, Nacro B, Sangaré L, Carrière C, Decré D, Ouégraogo R, Jean-Pierre H, Godreuil S.

BMC Infect Dis. 2016 Jul 11;16:326. doi: 10.1186/s12879-016-1655-3.

31.

Unconventional endosome-like compartment and retromer complex in Toxoplasma gondii govern parasite integrity and host infection.

Sangaré LO, Alayi TD, Westermann B, Hovasse A, Sindikubwabo F, Callebaut I, Werkmeister E, Lafont F, Slomianny C, Hakimi MA, Van Dorsselaer A, Schaeffer-Reiss C, Tomavo S.

Nat Commun. 2016 Apr 11;7:11191. doi: 10.1038/ncomms11191.

32.

Estimation of HIV-1 DNA Level Interfering with Reliability of HIV-1 RNA Quantification Performed on Dried Blood Spots Collected from Successfully Treated Patients.

Zida S, Tuaillon E, Barro M, Kwimatouo Lekpa Franchard A, Kagoné T, Nacro B, Ouedraogo AS, Bolloré K, Sanosyan A, Plantier JC, Meda N, Sangaré L, Rouzioux C, Rouet F, Kania D.

J Clin Microbiol. 2016 Jun;54(6):1641-1643. doi: 10.1128/JCM.03372-15. Epub 2016 Mar 23.

33.

First Description of IncX3 Plasmids Carrying blaOXA-181 in Escherichia coli Clinical Isolates in Burkina Faso.

Ouédraogo AS, Compain F, Sanou M, Aberkane S, Bouzinbi N, Hide M, Sangaré L, Ouédraogo-Traoré R, Jean-Pierre H, Vendrell J, Solassol J, Decré D, Godreuil S.

Antimicrob Agents Chemother. 2016 Apr 22;60(5):3240-2. doi: 10.1128/AAC.00147-16. Print 2016 May. No abstract available.

34.

First genome characterization of a novel hepatitis C virus genotype 5 variant.

Henquell C, Yameogo S, Sangaré L.

Infect Genet Evol. 2016 Apr;39:173-175. doi: 10.1016/j.meegid.2016.01.016. Epub 2016 Jan 22.

PMID:
26807921
35.

Apical Organelle Secretion by Toxoplasma Controls Innate and Adaptive Immunity and Mediates Long-Term Protection.

Sloves PJ, Mouveaux T, Ait-Yahia S, Vorng H, Everaere L, Sangare LO, Tsicopoulos A, Tomavo S.

J Infect Dis. 2015 Nov 1;212(9):1449-58. doi: 10.1093/infdis/jiv250. Epub 2015 Apr 24.

PMID:
25910629
36.

Complete genome sequence of Bacillus subtilis SG6 antagonistic against Fusarium graminearum.

Zhao Y, Sangare L, Wang Y, Folly YM, Selvaraj JN, Xing F, Zhou L, Wang Y, Liu Y.

J Biotechnol. 2015 Jan 20;194:10-1. doi: 10.1016/j.jbiotec.2014.11.033. Epub 2014 Dec 5.

PMID:
25483317
37.

Persistent low carriage of serogroup A Neisseria meningitidis two years after mass vaccination with the meningococcal conjugate vaccine, MenAfriVac.

Kristiansen PA, Ba AK, Ouédraogo AS, Sanou I, Ouédraogo R, Sangaré L, Diomandé F, Kandolo D, Saga IM, Misegades L, Clark TA, Préziosi MP, Caugant DA.

BMC Infect Dis. 2014 Dec 4;14:663. doi: 10.1186/s12879-014-0663-4.

38.

[Characterization of bacterial flora in community peritonitis carried out in Burkina Faso].

Sanou M, Ky A, Ouangre E, Bisseye C, Sanou A, Nagalo BM, Sanou D, Simporé J, Sangare L, Traore R.

Pan Afr Med J. 2014 May 5;18:17. doi: 10.11604/pamj.2014.18.17.3157. eCollection 2014. French. No abstract available.

39.

Aflatoxin B₁ degradation by a Pseudomonas strain.

Sangare L, Zhao Y, Folly YM, Chang J, Li J, Selvaraj JN, Xing F, Zhou L, Wang Y, Liu Y.

Toxins (Basel). 2014 Oct 23;6(10):3028-40. doi: 10.3390/toxins6103028. Erratum in: Toxins (Basel). 2015 Sep;7(9):3538-9.

40.

Evolution of meningococcal carriage in serogroups X and Y before introduction of MenAfriVac in the health district of Kaya, Burkina Faso.

Ba AK, Sanou I, Kristiansen PA, Sangaré L, Ouédraogo R, Ouattara K, Kienou M, Tiendrebeogo S, Tranchot J.

BMC Infect Dis. 2014 Oct 14;14:546. doi: 10.1186/s12879-014-0546-8.

41.

[Seroprevalence of HBs Ag and of anti-HCV antibodies among HIV infected people in N'Djamena, Chad].

Bessimbaye N, Moussa AM, Mbanga D, Tidjani A, Mahamat SO, Ngawara MN, Ngarnayal G, Fissou HY, Sangare L, Ndoutamia G, Barro N.

Bull Soc Pathol Exot. 2014 Dec;107(5):327-31. doi: 10.1007/s13149-014-0386-1. Epub 2014 Aug 26. French.

PMID:
25158842
42.

Water filter provision and home-based filter reinforcement reduce diarrhea in Kenyan HIV-infected adults and their household members.

Pavlinac PB, Naulikha JM, Chaba L, Kimani N, Sangaré LR, Yuhas K, Singa BO, John-Stewart G, Walson JL.

Am J Trop Med Hyg. 2014 Aug;91(2):273-80. doi: 10.4269/ajtmh.13-0552. Epub 2014 May 19.

43.

Antagonistic action of Bacillus subtilis strain SG6 on Fusarium graminearum.

Zhao Y, Selvaraj JN, Xing F, Zhou L, Wang Y, Song H, Tan X, Sun L, Sangare L, Folly YM, Liu Y.

PLoS One. 2014 Mar 20;9(3):e92486. doi: 10.1371/journal.pone.0092486. eCollection 2014.

44.

Streptococcus pneumoniae invasive infections in Burkina Faso, 2007 to 2011.

Chaïbou Y, Sanou I, Congo-Ouedraogo M, Kienou MC, Ouattara K, Somlaré H, Traoré AS, Sangaré L.

Med Mal Infect. 2014 Mar;44(3):117-22. doi: 10.1016/j.medmal.2014.01.014. Epub 2014 Mar 4.

PMID:
24612507
45.

Neisseria meningitidis serogroup W, Burkina Faso, 2012.

MacNeil JR, Medah I, Koussoubé D, Novak RT, Cohn AC, Diomandé FV, Yelbeogo D, Kambou JL, Tarbangdo TF, Ouédraogo-Traoré R, Sangaré L, Hatcher C, Vuong J, Mayer LW, Djingarey MH, Clark TA, Messonnier NE.

Emerg Infect Dis. 2014 Mar;20(3):394-9. doi: 10.3201/eid2003.131407.

46.

The association between malaria and iron status or supplementation in pregnancy: a systematic review and meta-analysis.

Sangaré L, van Eijk AM, Ter Kuile FO, Walson J, Stergachis A.

PLoS One. 2014 Feb 14;9(2):e87743. doi: 10.1371/journal.pone.0087743. eCollection 2014. Review.

47.

Implementation of a national external quality assessment program for medical laboratories in Burkina Faso: challenges, lessons learned, and perspectives.

Sakandé J, Nikièma A, Kabré E, Sawadogo C, Nacoulma EW, Sanou M, Sangaré L, Traoré-Ouédraogo R, Sawadogo M, Gershy-Damet GM.

Am J Clin Pathol. 2014 Feb;141(2):181-7. doi: 10.1309/AJCPXC83HIBBSRDT.

PMID:
24436264
48.

Impact of pre-analytical factors on mycobacterium cultures contaminations rates in Burkina Faso, West Africa.

Kaboré A, Hien H, Sanou A, Zingué D, Daneau G, Ganamé Z, Nouctara M, Ouédraogo M, Ouédraogo O, Koutou F, Gomgnimbou M, Méda N, Neveu D, Godreuil S, Sangaré L.

Pan Afr Med J. 2014 Dec 22;19:396. doi: 10.11604/pamj.2014.19.396.5551. eCollection 2014.

49.

Impact of helminth diagnostic test performance on estimation of risk factors and outcomes in HIV-positive adults.

Arndt MB, John-Stewart G, Richardson BA, Singa B, van Lieshout L, Verweij JJ, Sangaré LR, Mbogo LW, Naulikha JM, Walson JL.

PLoS One. 2013 Dec 4;8(12):e81915. doi: 10.1371/journal.pone.0081915. eCollection 2013.

50.

Antipneumococcal seroprevalence and pneumococcal carriage during a meningococcal epidemic in Burkina Faso, 2006.

Yaro S, Njanpop-Lafourcade BM, Drabo A, Idohou RS, Kroman SS, Sanou O, Traoré Y, Sangaré L, Diagbouga SP, Koeck JL, Borrow R, Gessner BD, Mueller JE.

J Infect Dis. 2014 Apr 15;209(8):1241-50. doi: 10.1093/infdis/jit641. Epub 2013 Nov 25.

PMID:
24277740

Supplemental Content

Loading ...
Support Center